product summary
Loading...
company name :
OriGene
product type :
protein
product name :
Protein Kinase A regulatory subunit I alpha (PRKAR1A) (NM_212472) Human Recombinant Protein
catalog :
TP312810
quantity :
20 µg
price :
867 USD
more info or order :
product information
SKU :
TP312810
Category :
Proteins
Sub-Category :
Recombinant Proteins
Name :
Protein Kinase A regulatory subunit I alpha (PRKAR1A) (NM_212472) Human Recombinant Protein
Description :
Recombinant protein of human protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) (PRKAR1A), transcript variant 3
Size :
20 µg
Price US :
867 USD
Delivery Time US :
In Stock
Symbol :
PRKAR1A
Uniprot ID :
P10644, B2R5T5
Accn :
NM_212472
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
related products
browse more products
- JNK2 (MAPK9) (NM_002752) Human Recombinant Protein | TP312814
- MEF2A (NM_005587) Human Recombinant Protein | TP312830
- Parathyroid hormone related protein (PTHLH) (NM_002820) Human Recombinant Protei ...
- TBX10 (NM_005995) Human Recombinant Protein | TP312862
- ALKBH3 (NM_139178) Human Recombinant Protein | TP312873
questions and comments